About this trial
The goal of this clinical trial is to to determine the extent of the association between objective changes in the muscle function of the knee extensors (strength and power) and the function reported by the patient following ACL reconstruction surgery. The main questions it aims to answer is:
\- Pre- and post-operative (6 months) changes in maximum knee extensor strength following ACL reconstruction, correlated with the IKDC-SKF score.
Eligibility criteria
Qualifiers
Patients requiring isolated or complex ACL reconstruction (combined with a meniscal injury)
Patients who are physically active (Tegner score ≥ 4) and wish to resume such activity.
Patients with no history of surgery on the ipsilateral knee (i.e., native knee).
Patients able to comply with the study procedures
Disqualifiers
Patient with comprehension difficulties
Recurrent rupture of the ipsilateral ACL
Multi-ligament injuries (i.e., injury to the medial collateral ligament, lateral collateral ligament or posterior cruciate ligament)
Trial design
Treatments tested in this trial
- assessment
Treatment groups
Sponsors and collaborators
Centre Hospitalier Metropole Savoie
Lead sponsor
Université Savoie Mont Blanc
Collaborator